HIV ‘Cure’ on the Horizon? London Patient Cleared of AIDS Virus
Hopes have been raised of a cure for AIDS after a patient in London became free of the HIV virus following a bone…
Oxford BioMedica
Last updated: 13.02.2014
Address: Medawar Centre, Robert Robinson Avenue, The Oxford Science Park, Oxford, OX4 4GA,United Kingdom
Tel: +44 (0) 1865 783 000
Web: http://www.oxfordbiomedica.co.uk/
Company description
Oxford BioMedica has established a platform of technologies in gene delivery and immunotherapy, protected by an extensive intellectual property estate. Through in-house and collaborative development, the Company has a broad pipeline of gene-based product candidates for the treatment of age-related or inherited neurodegenerative and ocular diseases. In addition, Oxford BioMedica and its collaborators are developing novel targeted therapies and therapeutic vaccines to treat multiple types of cancer.
Products and services
Oxford BioMedica’s two lead programmes are a gene therapy for Parkinson’s disease (ProSavin®) in Phase I/II development and a therapeutic cancer vaccine (TroVax®) in Phase II development.
The other products include RetinoStat®, StarGen™, UshStat™, EncorStat™, MoNuDin®, Hi-8® MEL, MetXia®, EndoAngio-GT and Targeted Antibody Therapy.
Related
Company Profile: GW Pharmaceuticals
Founded in 1998, GW Pharmaceuticals is a British biopharmaceutical company, best known for being the only company…
The European Medicines Verification System Launches to Tackle Fake Drugs
The 9th February 2019 marked the launch of the European Medicines Verification System (EMVS) which will use…
The UK to Incentivise Big Pharma Firms to Develop New Antibiotics
In recent years, apocalyptic conversations around superbugs caused by antimicrobial resistance (AMR) have been on…
The 5 Most Influential Medical Research Charities in the UK
An unusual characteristic of the UK’s healthcare landscape is that charities fund the vast majority of…
GSK and Pfizer Consumer Health Divisions to Merge
The two Big Pharma giants today announced the merger between their consumer healthcare businesses, with the joint…
The Line Manager of Tomorrow
Ian Chamberlain looks at the changing role of the pharma sales manager and the skills needed to keep up with new…
Nationalism & Populism: A Roadblock for Global Pharma
Aditya Bhattacharji manages Eurasia Group‘s healthcare analysis. In his second piece for PharmaBoardroom,…
The Changing Role of the Medical Rep
With more than 25 years pharmaceutical industry experience, Ian Chamberlain provides training to help pharma…
Brexit uncertainty forces AstraZeneca to freeze investment in the UK
Yesterday, pharma giant AstraZeneca announced that they have halted investment in the UK due to lack of clarity on…
The UK will add folic acid to flour to reduce defects in newborns
The UK Prime Minister has been convinced by medical professionals to fortify all flour with folic acid to reduce…
NHS launches a new era of genomic medicine
This week the NHS becomes the first in the world to routinely offer access to breakthrough genomic medicine. Today…
